Patent classifications
C07D491/044
OXAZIRIDINE COMPOUND AND PRODUCTION METHOD THEREOF
Provided are an oxaziridine compound showing an antifungal activity and cytotoxicity and expected as a new antifungal agent or anticancer agent, and a production method thereof.
A compound represented by the formula 1:
##STR00001##
wherein
X is a single bond, —C(H) (R.sup.6)— or —C(H) (R.sup.7)—C(H)(R.sup.8)—; and
R.sup.1-R.sup.8 are each independently a hydrogen atom, an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, or a salt thereof.
N-substituted indoles and other heterocycles for treating brain disorders
The present invention provides N-substituted indoles and other heterocycles and methods of using the compounds for treating brain disorders.
N-substituted indoles and other heterocycles for treating brain disorders
The present invention provides N-substituted indoles and other heterocycles and methods of using the compounds for treating brain disorders.
SUBSTITUTED THIOHYDANTOIN DERIVATIVES AS ANDROGEN RECEPTOR ANTAGONISTS
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the antagonism of one or more androgen receptor types. Such compounds are represented by Formula (I) as follows:
##STR00001##
wherein R.sub.1 and G are defined herein.
Enantiomeric separation and purification of 2,3,4,9-tetrahydro-1H-carbazole-4-carboxylic acid amide derivatives
A method for the purification of cyclic indole compounds that provides advantages over previously-known methods. Using the method of the present invention allows for the facile preparation of a good quality solid form of these compounds.
Factor XIa inhibitors
The present invention provides a compound of Formula (I) ##STR00001##
and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoaguability or fibrotic changes.
Factor XIa inhibitors
The present invention provides a compound of Formula (I) ##STR00001##
and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoaguability or fibrotic changes.
PROTEASE INHIBITORS, PREPARATION, AND USES THEREOF
The disclosure provides at compounds of Formula I, compositions comprising the same, and methods of using the same, including use in treating a disease and/or a symptom of a disease caused by a coronavirus.
##STR00001##
PROTEASE INHIBITORS, PREPARATION, AND USES THEREOF
The disclosure provides at compounds of Formula I, compositions comprising the same, and methods of using the same, including use in treating a disease and/or a symptom of a disease caused by a coronavirus.
##STR00001##
Nitrogenous tricyclic compounds and uses thereof in medicine
Nitrogenous tricyclic compounds and uses thereof in medicine, in particular, a novel nitrogenous tricyclic compound used as an FXR active regulator and a stereoisomer, a geometrical isomer, a tautomer, a N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, and use of the compound in the manufacture of a drug for treating a disease and/or disorder regulated by FXR. A pharmaceutically acceptable composition containing the compound and a method of treating a disease and/or disorder mediated by FXR comprising administering the compound or pharmaceutical composition thereof.